Bimzelx (Bimekizumab)
Bimzelx (Bimekizumab) is a biologic medicine that suppresses the immune system in order to treat psoriatic arthritis, ankylosing spondylitis, and psoriasis.
Bimzelx works by blocking interleukin-17 (IL-17), a signalling protein (cytokine) that regulates the immune system and is related to the body's inflammatory response.
Taking Bimzelx
Bimzelx is available as a subcutaneous (under the skin) injection.
The manufacturer of Bimzelx offers a support program to Canadian patients that are prescribed the medication:
Patient support program enrolment formsImportant Tests and Risks
Science
Safety
Drug Identification Number (DIN)
02525267 (Prefilled Syringe)
02525275 (Autoinjector)